On Friday, UBS has increased its price target on Lululemon Athletica Inc. (NASDAQ: NASDAQ:LULU) shares, adjusting the figure to $360 from the previous target of $315, while maintaining a Neutral rating on the stock.
The adjustment reflects the firm's consideration of the company's potential to return to its historical sales growth rates in the Americas. According to InvestingPro data, the company maintains a "GREAT" financial health score and currently appears undervalued based on their proprietary Fair Value model.
Lululemon's third-quarter sales in the Americas saw a modest year-over-year increase of 2%, with U.S. revenues remaining flat. The focal point for analysts and investors alike is whether Lululemon can reestablish the level of product innovation that historically drove its sales.
The company has indicated expectations of returning to its traditional levels of product newness by the first quarter of 2025. Despite recent challenges, the company maintains impressive gross margins of 58.5% and has achieved 13% revenue growth over the last twelve months.
The future direction of Lululemon's growth rate in the Americas is pivotal to the company's long-term earnings outlook and its price-to-earnings ratio. Market participants are awaiting confirmation that Lululemon can fulfill its innovation promises and rejuvenate U.S. business growth. The stock's performance is anticipated to be contained within a certain range until there is clarity on these aspects. InvestingPro analysis reveals the stock trades at an attractive PEG ratio of 0.4, suggesting potential value relative to its growth prospects. Discover 10+ additional exclusive insights and detailed valuation metrics with InvestingPro's comprehensive research reports.
Investors and analysts are looking forward to Lululemon's commentary at the upcoming ICR Conference in January as a potential indicator of the company’s trajectory. Observations of product newness in the first quarter of 2025 will be particularly scrutinized to assess the company’s ability to meet its targets.
UBS has expressed a lack of conviction regarding the outcome of Lululemon's initiatives to drive growth and innovation. This uncertainty results in an anticipated balanced risk-reward scenario for the stock, as the market seeks to determine the likelihood of Lululemon achieving its stated objectives.
In other recent news, Lululemon Athletica Inc. has seen several major developments. After exceeding third-quarter earnings expectations, the company received multiple price target revisions. BTIG raised the target to $430, maintaining a Buy rating, following the company's impressive gross profit margins and strong profitability metrics. Telsey Advisory Group, Bernstein, Raymond (NS:RYMD) James, and Citi also revised their price targets to $430, $360, $400, and $380 respectively, reflecting optimism about Lululemon's future performance.
Maintaining an Outperform rating, Raymond James raised the price target to $400, citing the company's third-quarter earnings beat and the brand's sustained growth prospects, particularly in international markets.
Lululemon's third-quarter earnings per share of $2.87 and a 9% revenue growth to $2.40 billion surpassed expectations. The company's international growth, particularly in China, was noted as a key driver of this performance. However, the fiscal year 2024 sales growth forecast was revised from 11-12% to 8-9%.
Several analyst firms have maintained positive ratings on the company. TD (TSX:TD) Cowen adjusted the price target to $383, highlighting Lululemon's robust 30% year-over-year growth in international markets. Citi, maintaining a neutral stance, upgraded Lululemon's price target to $380. Analyst firms like Morgan Stanley (NYSE:MS), Baird, and Truist Securities have responded positively to these developments, adjusting their price targets to reflect current trends.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.